Us-fda News: Read Latest News & Live Updates on Us-fda, Photos, Videos at CNBCTV18.com

homeUs Fda News

Us Fda NEWS

All

healthcare | May 19, 2023 10:17 AM IST
US FDA issues Establishment Inspection Report for Strides Pharma’s Puducherry facility
healthcare | May 10, 2023 8:45 AM IST
US FDA issued guidance on potential of glycerin & other drug components being contaminated with toxic substances DEG or EG
earnings | May 8, 2023 4:52 PM IST
Lupin Q4 earnings preview: Domestic market likely to pick up, margins may improve
market | Apr 25, 2023 4:46 PM IST
Zydus Lifesciences gets US FDA nod to market Metronidazole Topical cream in US
business | Apr 23, 2023 1:41 PM IST
Sun Pharma shares fall after USFDA halts shipments to the US from Mohali facility
business | Apr 18, 2023 8:20 PM IST
Piramal Pharma shares rise after USFDA closes inspection at US-based facility
business | Mar 23, 2023 4:38 PM IST
Lupin gets tentative US FDA approval for Obeticholic Acid Tablets
business | Mar 18, 2023 6:23 PM IST
US FDA issues Form 483 with three observations for Bliss GVS Pharma’s Palghar unit
business | Mar 17, 2023 7:20 PM IST
US FDA issues one observation for Torrent Pharma’s Gujarat unit
healthcare | Mar 10, 2023 7:12 PM IST
US FDA concludes Lupin’s Vizag facility inspection with no observations
business | Feb 27, 2023 8:16 AM IST
Granules get US FDA nod for Hypertension tablets Losartan Potassium
market | Feb 23, 2023 7:38 PM IST
US FDA concludes inspection at Alkem Laboratories' Indore facillity
healthcare | Feb 6, 2023 9:01 PM IST
Tamil Nadu-based Global Pharma recalls eye drops from US markets
healthcare | Feb 3, 2023 9:22 PM IST
Indian drug controller begins action against Global Pharma after USFDA warning on artificial tears product
business | Nov 8, 2022 9:24 AM IST
USFDA finds procedural issues at Lupin’s Nagpur injectables plant

Us Fda NEWS

US FDA issues Establishment Inspection Report for Strides Pharma’s Puducherry facility

US FDA issued guidance on potential of glycerin & other drug components being contaminated with toxic substances DEG or EG

Lupin Q4 earnings preview: Domestic market likely to pick up, margins may improve

Zydus Lifesciences gets US FDA nod to market Metronidazole Topical cream in US

Sun Pharma shares fall after USFDA halts shipments to the US from Mohali facility

Piramal Pharma shares rise after USFDA closes inspection at US-based facility

Lupin gets tentative US FDA approval for Obeticholic Acid Tablets

US FDA issues Form 483 with three observations for Bliss GVS Pharma’s Palghar unit

US FDA issues one observation for Torrent Pharma’s Gujarat unit

US FDA concludes Lupin’s Vizag facility inspection with no observations

Granules get US FDA nod for Hypertension tablets Losartan Potassium

US FDA concludes inspection at Alkem Laboratories' Indore facillity

Tamil Nadu-based Global Pharma recalls eye drops from US markets

Indian drug controller begins action against Global Pharma after USFDA warning on artificial tears product

USFDA finds procedural issues at Lupin’s Nagpur injectables plant